Jump to content

Oldest pages

Pharmacopedia
BrowseCategoriesLog in

Showing below up to 50 results in range #1,101 to #1,150.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Effect:Visual acuity enhancement (06:00, 13 June 2026)
  2. Effect:Visual acuity suppression (06:00, 13 June 2026)
  3. Effect:Visual disconnection (06:00, 13 June 2026)
  4. Effect:Visual flipping (06:00, 13 June 2026)
  5. Effect:Visual haze (06:00, 13 June 2026)
  6. Effect:Visual processing acceleration (06:00, 13 June 2026)
  7. Effect:Visual processing deceleration (06:00, 13 June 2026)
  8. Effect:Visual stretching (06:00, 13 June 2026)
  9. Effect:Vomiting (06:00, 13 June 2026)
  10. Effect:Wakefulness (06:00, 13 June 2026)
  11. Effect:Watery eyes (06:00, 13 June 2026)
  12. Effect:Weight gain (06:00, 13 June 2026)
  13. Effect:Weight loss (06:00, 13 June 2026)
  14. Effect:Withdrawal/Discontinuation Syndrome (06:00, 13 June 2026)
  15. Problem:Acne (06:00, 13 June 2026)
  16. Problem:Acute Stress Disorder (06:00, 13 June 2026)
  17. Problem:Acute pain (06:00, 13 June 2026)
  18. Problem:Agitation (06:00, 13 June 2026)
  19. Problem:Agitation in the setting of dementia (06:00, 13 June 2026)
  20. Problem:Agoraphobia (06:00, 13 June 2026)
  21. Problem:Alcohol Use Disorder (06:00, 13 June 2026)
  22. Problem:Allergic rhinitis (06:00, 13 June 2026)
  23. Problem:Alzheimer disease (06:00, 13 June 2026)
  24. Problem:Anorexia Nervosa (06:00, 13 June 2026)
  25. Problem:Antisocial Personality Disorder (06:00, 13 June 2026)
  26. Problem:Anxiety (06:00, 13 June 2026)
  27. Problem:Anxiety disorders broadly (06:00, 13 June 2026)
  28. Problem:Asthma (06:00, 13 June 2026)
  29. Problem:Atrial fibrillation (06:00, 13 June 2026)
  30. Problem:Attention Deficit Disorder (predominantly inattentive) (06:01, 13 June 2026)
  31. Problem:Attention-Deficit/Hyperactivity Disorder (06:01, 13 June 2026)
  32. Problem:Autism Spectrum Disorder (06:01, 13 June 2026)
  33. Problem:Avoidant Personality Disorder (06:01, 13 June 2026)
  34. Problem:Avoidant/Restrictive Food Intake Disorder (06:01, 13 June 2026)
  35. Problem:BPH (06:01, 13 June 2026)
  36. Problem:Binge-Eating Disorder (06:01, 13 June 2026)
  37. Problem:Bipolar Affective Disorder (06:01, 13 June 2026)
  38. Problem:Bipolar Disorder (06:01, 13 June 2026)
  39. Problem:Bipolar I Disorder (06:01, 13 June 2026)
  40. Problem:Bipolar II Disorder (06:01, 13 June 2026)
  41. Problem:Body Dysmorphic Disorder (06:01, 13 June 2026)
  42. Problem:Borderline Personality Disorder (06:01, 13 June 2026)
  43. Problem:Bulimia Nervosa (06:01, 13 June 2026)
  44. Problem:COPD (06:01, 13 June 2026)
  45. Problem:Cancer-Related Distress (06:01, 13 June 2026)
  46. Problem:Cannabis Use Disorder (06:01, 13 June 2026)
  47. Problem:Cardiovascular risk reduction in obesity (06:01, 13 June 2026)
  48. Problem:Cardiovascular risk reduction in type 2 diabetes (06:01, 13 June 2026)
  49. Problem:Chronic Fatigue Syndrome (06:01, 13 June 2026)
  50. Problem:Chronic kidney disease in type 2 diabetes (06:01, 13 June 2026)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:AncientPages"